USAA
TOVX icon

United Services Automobile Association’s Theriva Biologics TOVX Stock Holding History

United Services Automobile Association’s Portfolio TOVX Stock Details TOVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-2
Closed -$3K – 2357
2018
Q2 		$3K Hold
2
– – ﹤0.01% 2300
2018
Q1 		$4K Buy
+2
New +$7.61K ﹤0.01% 2276

Other funds holding TOVX

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

United Services Automobile Association's TOVX Position: Q3 2018 in Review

United Services Automobile Association sold out of Theriva Biologics (TOVX) in Q3 2018, closing a stake of 2 shares — an estimated $3K sold.

United Services Automobile Association first reported a position in TOVX in Q1 2018 and held it in 2 quarters. The position peaked at $4K in Q1 2018. 22 funds tracked by Wall St. Rank hold TOVX as of Q3 2018.

  • United Services Automobile Association reported no remaining Theriva Biologics position as of Q3 2018 after selling out during the quarter.
  • United Services Automobile Association sold 2 Theriva Biologics shares in Q3 2018, an estimated $3K.
  • United Services Automobile Association first reported a position in Theriva Biologics in Q1 2018 and held it in 2 quarters.
  • United Services Automobile Association's Theriva Biologics position peaked at $4K in Q1 2018.
  • 22 funds tracked by Wall St. Rank held Theriva Biologics as of Q3 2018.

Based on United Services Automobile Association's 13F filing for Q3 2018, filed 13 Nov 2018.